Tag: MediPharm Labs Corp.

August 13, 2019

MediPharm Labs Reports Strong, Profitable Second Quarter Results

Q2 2019 Revenue of $31.5 Million, Adjusted EBITDA of $7.7 Million, Net Income before tax of $4.1 Million
August 1, 2019

MediPharm Labs Sets Date to Announce Second Quarter 2019 Financial Results

MediPharm Labs Corp. (TSX:LABS, OTCQX:MEDIF, FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation,...
July 25, 2019

MediPharm Labs Announces Trading Date on the Toronto Stock Exchange

MediPharm Labs Corp. (TSXV:LABS) is pleased to announce that its common shares are expected to begin trading on the Toronto...
July 18, 2019

MediPharm Labs Conditionally Approved to Graduate to the TSX

MediPharm Labs Corp. (TSXV:LABS) (OTCQX:MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation,...
July 16, 2019

MediPharm Labs Provides Operational Update and Increases Average Weekly Production of Active Cannabinoid Component to 75 Million Milligrams

MediPharm Labs Corp. (TSXV:LABS, OTCQX:MEDIF, FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation,...
June 24, 2019

MediPharm Labs Receives Permits and Ships First Medical Cannabis Concentrate to Australia

Through its wholly owned subsidiary, MediPharm Labs Inc., the Company has become the first Canadian extraction-only company to publicly announce...
June 19, 2019

MediPharm Labs and Ace Valley Enter Vape Oil White Label Deal

MediPharm Labs Corp. (TSXV: LABS, OTCQX: MEDIF, FSE: MLZ), is pleased to announce a white label agreement dated June 18,...